Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • Reporting Rate Calculator
  • Signal Detection
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Myocarditis
  • Guillain-Barré
  • Allergic Reactions
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenImmigration
  • OpenCrime
  • OpenSubsidies
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • WarCosts
  • OpenPrescriber
  • GiveScope
  • SPACGraveyard
  • AI Exposure
  • TariffTax
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Symptoms
  3. Exposure to SARS-CoV-2

Exposure to SARS-CoV-2

3,826 total reports30.5% serious outcomes
Share

Exposure to SARS-CoV-2 appears in 3,826 VAERS reports across all vaccines. Of these, 147 reports also mentioned death and 1,020 involved hospitalization. The severity rate (deaths + hospitalizations as a percentage of reports) is 30.5%. The top vaccines associated with this symptom are COVID-19, COVID-19 (Bivalent), Flu (Quadrivalent). Remember: VAERS reports show temporal association, not causation.

3,826
Total Reports
147
Deaths
1,020
Hospitalizations
30.5
Severity Rate
% serious outcomes

💡 Key Insights

→COVID-19 accounts for 113% of all Exposure to SARS-CoV-2 reports — this reflects the volume of COVID-19 doses administered, not a unique safety concern.
→Severity rate of 30.5% is 3.5× the database average. This suggests Exposure to SARS-CoV-2 tends to appear in more serious reports, though it may also be reported alongside other serious conditions.
→2021 saw the most reports (2,201) — likely driven by the COVID-19 vaccine rollout and heightened VAERS awareness.
→Reported across 10 different vaccines — appearing in multiple vaccine types suggests it may be a general immune response.

About Exposure to SARS-CoV-2 Reports

Exposure to SARS-CoV-2 has been reported 3,826 times in VAERS from 1990 to 2026.

Of these reports, 147 were associated with death (3.84%) and 1,020 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Exposure to SARS-CoV-2 is 30.5%.

Understanding Exposure to SARS-CoV-2 in VAERS

•Temporal association only: These reports show Exposure to SARS-CoV-2 occurred after vaccination, not necessarily because of vaccination.
•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.
•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.
•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Exposure to SARS-CoV-2. This may reflect usage patterns, not causation.
Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.
Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.

Most Associated Vaccines

1. COVID-194,318
2. COVID-19 (Bivalent)417
3. Flu (Quadrivalent)54
4. Unknown Vaccine37
5. Flu (Seasonal)31
6. FLUA417
7. Shingles (Zostavax)12
8. Flu (Cell-Based Quad)4
9. Pneumococcal (PPV23)3
10. Tdap3
View all vaccines →

Detailed Breakdowns

Exposure to SARS-CoV-2 × COVID-19 →Exposure to SARS-CoV-2 × COVID-19 (Bivalent) →Exposure to SARS-CoV-2 × Flu (Quadrivalent) →

Quick Facts

Reports:3,826
Deaths:147
Hospitalizations:1,020
Mortality Rate:3.84%
Severity Rate:30.5%

Related Analysis

Most Common Symptoms Analysis →Serious Outcomes Analysis →When Do Side Effects Start? →Recovery Rates Analysis →

Explore Further

Compare with Other SymptomsRead Symptoms Analysis

Data Source

This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.